Patient recruitment is one of the essential parts in clinical trials which can determine the success in the particular study. To choose the right patient enrollment strategy and to be updated in this area of expertise, these are the elements which can differentiate your clinical trials. Without sufficient patient retention your clinical studies would indicate as too small. That is why the topic of patient recruitment and retention may continue as one of the biggest question in this area for the next years.

All pharmaceutical companies are hungry to find new strategies, because choosing the right strategy can influence not only the final success of the clinical trial but also it can be budget friendly, time saving and it could simplify the patient enrollment. These factors are nominal in every company and they have notable impact on achieving accomplishment in this environment.

Pharmaceutical companies in current market usually fight for the patients in specific therapeutic areas in order to increase the number of patients in their very own studies. Improving the patient recruitment in clinical trials gives to these companies one of the biggest chances to speed up the process as patient enrollment is the most time-consuming part of clinical trial. These days, when the number of subjects for the clinical studies increased occur also new problems such as ethical considerations, safety, regulatory frameworks.

Currently, a number of companies are facing the same challenge in the recruitment. Missing the time limits in patient enrollment is closely associated with additional expenses. The recruitment and retention problems largely influence the costs determined for the particular study. A big amount of money is spent on the research. That is the reason why this environment is so challenging.

If the industry wants to develop they have to alter their traditional ways, tools and practices of recruiting. The challenges in current environment are significant for all of the pharmaceutical companies which want to run successful clinical trials. But recruitment of the patients for the studies is only the beginning of the path. There is no value added if there are a number of right subjects in the trial when they will drop out before the trial comes to an end. Therefore the improvement of retention strategies is necessary. Strategies which would keep participants informed and convinced and which would assure that they will stay within the trial until the very end of it.

4th Annual Patient Recruitment and Retention in Pharma will focus on the transformation of patient recruitment in the biggest pharmaceutical companies across Europe. Senior level decision makers from these companies will share their own experiences and case studies as well. Delegates can hear about unique topics presented by experienced professionals from the biggest European pharmaceutical companies.